|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue: | |||||
| Collaboration revenue - related party | |||||
| Grant revenue | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| Research and development expenses | |||||
| General and administrative expenses | |||||
| Restructuring expenses | |||||
| Collaboration (profit) loss sharing - related party | |||||
| Manufacturing services | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Gain on sale of VOWST Business | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Total other income (expense), net | |||||
| Net income (loss) from continuing operations | |||||
| Net income from discontinued operations, net of tax | |||||
| Net income (loss) | |||||
| Net income (loss) from continuing operations per share attributable to common stockholders - basic | |||||
| Net income from discontinued operations per share attributable to common stockholders - basic | |||||
| Net income (loss) per share attributable to common stockholders - basic | |||||
| Net income (loss) from continuing operations per share attributable to common stockholders - diluted | |||||
| Net income from discontinued operations per share attributable to common stockholders - diluted | |||||
| Net income (loss) per share attributable to common stockholders - diluted | |||||
| Weighted average common shares outstanding - basic | |||||
| Weighted average common shares outstanding - diluted | |||||
| Other comprehensive income: | |||||
| Unrealized gain on investments, net of tax of $0 | |||||
| Currency translation adjustment | |||||
| Total other comprehensive income | |||||
| Comprehensive income (loss) | |||||
Loading...